Theriva™ Biologics Announces Positive Topline Data From Investigator Sponsored Phase 1 Trial of Intravitreal Vcn-01 in Pediatric Patients With Refractory Retinoblastoma
Theriva™ Biologics公布了研究人员赞助的针对难治性视网膜母细胞瘤儿科患者的玻璃体内Vcn-01的1期试验的积极数据
Theriva™ Biologics Announces Positive Topline Data From Investigator Sponsored Phase 1 Trial of Intravitreal Vcn-01 in Pediatric Patients With Refractory Retinoblastoma
Theriva™ Biologics公布了研究人员赞助的针对难治性视网膜母细胞瘤儿科患者的玻璃体内Vcn-01的1期试验的积极数据
使用浏览器的分享功能,分享给你的好友吧